Screening for this disease may include molecular tests to look for mutations in FLT3-R and NPM-1, as well as BM bx with flow cytometry.
Screening for this disease may include molecular tests to look for mutations in FLT3-R and NPM-1, as well as BM bx with flow cytometry. Staining of myeloperoxidase can be used to test for the acute form of this disease and it is the presence of myeloperoxidase that is responsible for the green color of chloromas, which are most often found in patients with this disease. (*) One abnormality linked to this disease makes a BCR-ABL gene by reciprocal translocation between chromosomes 9 and 22. That is the Philadelphia Chromosome and often results in the chronic myelogenous form of this disease. In addition to that form, this disease has a lymphocytic variety which most often affects B-cells. For 10 points, name this cancer of the blood or marrow where non-functional white blood cells replicate out of control.
Screening for this disease may include molecular tests to look for mutations in FLT3-R and NPM-1, as well as BM bx with flow cytometry.
leukemia (accept lymphoma until myeloperoxidase)